Zhou Lan - Hemostasis Today | Hemostasis News, Insights, Stories

Voices Science Insight Innovation

Headlines Hematology Health Medicine VTE ASH Plasma Donation

March, 2026

Zhou Lan

Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm

Nov 26, 2025, 04:51 | Science

Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm

Emma P. with Clinical Research Professionals shared a post on LinkedIn: "Apixaban for Extended Treatment…

Gregory Piazza on CORONA-VTE Network Analysis

Oct 28, 2025, 13:09 | Science

Gregory Piazza on CORONA-VTE Network Analysis

Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…

Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines

Oct 12, 2025, 10:14 | Science

Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines

Hatim Lokhandwala, Clinical Research Coordinator, Hope & Healing Cancer Services LLC, shared a post on LinkedIn:…

Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress

Sep 16, 2025, 11:25 | Science

Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress

Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on…

Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results

Aug 31, 2025, 07:23 | Science

Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results

Marc Carrier, Professor at Ottawa Hospital Research Institute, has posted on X: ''New in…

Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results

Aug 30, 2025, 14:43 | Science

Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results

Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, shared a…

All: 6 Posts: 1 - 100

'

Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders

'

Philip Wells Honored with the 2026 ISTH Esteemed Career Award

'

Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis

'

Gevorg Tamamyan Joins The London Global Cancer Week Steering Group

'

Heghine Khachatryan: How DOACs Can Cause False-Positive FVIII Inhibitor Results

Mar 9, 2026, 15:20
Anthony Yazbeck։ The ‘Golden Blood’ – The World’s Rarest Blood Type
Mar 9, 2026, 15:13
Ali Al Janaahi: Clinical Insights on Recurrent Stroke in Neuro‑Behçet Disease at DINC 2026
Mar 9, 2026, 14:39
Tareq Abadl: Quick Clinical Interpretation of Hepatitis B Markers
Mar 9, 2026, 14:32
Sumedha Dash: What Happens Before a Blood Bag Reaches the Patient?
Mar 9, 2026, 14:26
Augustina Isioma Ikusemoro: Women Powering the Future of Blood Transfusion
Mar 9, 2026, 14:10
Jecko Thachil: The Journey of Protamine – From Heparin Reversal to Potential Gene Therapy Applications
Mar 9, 2026, 14:10
Advocating for the Bleeding Disorders Community at NBDF 2026 Washington Days – Hemophilia of Georgia
Mar 9, 2026, 14:05
Ramy Abdelnaby: The Impact of Multiterritory Brain Infarcts on Recurrent Stroke Risk and Anticoagulation Efficacy
Mar 9, 2026, 13:55
Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD